Literature DB >> 24867841

Strictly unilateral headaches: considerations of a clinician.

Gennaro Bussone1.   

Abstract

The aim of the lecture is to draw attention to the role that clinical practice and clinical observation have had in stimulating research on the pathophysiology of cluster headache (CH) and other trigeminal autonomic cephalalgias (TACs). The symptoms of cluster headache-in particular the typical circadian periodicity of the headaches and the seasonal recurrence of cluster periods-were fundamental in shifting attention away from peripheral pathogenetic hypotheses to the idea that cluster headache could have a central origin. Initially, solid neuroendocrinological data pointed to hypothalamic involvement. For example, CH patients were shown to have alterations in biorhythms. Subsequently, modern functional neuroimaging techniques were able to demonstrate that the homolateral posterior hypothalamus is activated during TAC headaches, so implicating this region in TAC pathogenesis. It is known that the hypothalamus has a modulatory effect on nociceptive and autonomic pathways, particularly on the nociceptive trigeminovascular system. Future research should clarify whether the hypothalamus is the generator of TAC headaches, or whether it is activated in response to an alteration of the homeostatic equilibrium between limbic emotional-affective components and autonomic-nociceptive components modulated by the hypothalamus.

Entities:  

Mesh:

Year:  2014        PMID: 24867841     DOI: 10.1007/s10072-014-1746-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  29 in total

1.  Stereotactic stimulation of posterior hypothalamic gray matter in a patient with intractable cluster headache.

Authors:  M Leone; A Franzini; G Bussone
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

2.  Recurrent brief headache in cluster pattern.

Authors:  E C KUNKLE; J B PFEIFFER; W M WILHOIT; L W HAMRICK
Journal:  Trans Am Neurol Assoc       Date:  1952

3.  Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo.

Authors:  M Leone; D D'Amico; F Frediani; F Moschiano; L Grazzi; A Attanasio; G Bussone
Journal:  Neurology       Date:  2000-03-28       Impact factor: 9.910

4.  Shortlasting unilateral neuralgiform headache attacks with conjunctival injection, tearing, sweating, and rhinorrhea.

Authors:  O Sjaastad; C Saunte; R Salvesen; T A Fredriksen; A Seim; O D Røe; K Fostad; O P Løbben; J M Zhao
Journal:  Cephalalgia       Date:  1989-06       Impact factor: 6.292

5.  Persistence of attacks of cluster headache after trigeminal nerve root section.

Authors:  Manjit S Matharu; Peter J Goadsby
Journal:  Brain       Date:  2002-05       Impact factor: 13.501

Review 6.  The hypothalamic orexinergic system: pain and primary headaches.

Authors:  Philip Holland; Peter J Goadsby
Journal:  Headache       Date:  2007-06       Impact factor: 5.887

7.  Long-term follow-up of bilateral hypothalamic stimulation for intractable cluster headache.

Authors:  M Leone; A Franzini; G Broggi; A May; G Bussone
Journal:  Brain       Date:  2004-08-25       Impact factor: 13.501

8.  "Hemicrania continua": another headache absolutely responsive to indomethacin.

Authors:  O Sjaastad; E L Spierings
Journal:  Cephalalgia       Date:  1984-03       Impact factor: 6.292

9.  Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system.

Authors:  P J Goadsby; L Edvinsson; R Ekman
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

10.  Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies.

Authors:  P J Goadsby; L Edvinsson
Journal:  Brain       Date:  1994-06       Impact factor: 13.501

View more
  1 in total

Review 1.  Appropriate use of neuroimaging in headache.

Authors:  Deena E Kuruvilla; Richard B Lipton
Journal:  Curr Pain Headache Rep       Date:  2015-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.